Q1 2026 Elekta AB (publ) Earnings Call Transcript
Key Points
- Elekta AB (EKTAF) reported a net sales increase of 3% in constant currencies, driven by strong momentum in Europe.
- The company launched new products, Elekta Evo and Elekta ONE, which are gaining traction and contributing positively to growth.
- Elekta's cash flow after continuous investments improved by SEK529 million year over year, mainly due to better working capital management.
- The EMEA region saw a 15% sales increase in constant exchange rates, driven by strong performance in Europe and new product launches.
- Elekta's Leksell Gamma Knife received FDA clearance for treating certain types of epilepsy, expanding its stereotactic radiosurgery capabilities.
- The adjusted gross margin declined to 37% from 37.8% last year, impacted by foreign exchange rates and increased tariff costs.
- The adjusted EBIT margin decreased to 6.5% from 7.4% last year, due to lower gross margin and higher net R&D expenses.
- Americas sales declined by 4% in constant exchange rates, with lower sales in North America due to customers awaiting Elekta Evo clearance.
- APAC sales declined by 4% in constant exchange rates, mainly due to lower volumes in China and India.
- The company faces ongoing challenges from US tariffs, with a negative impact on the adjusted gross margin of 90 basis points in Q1.
()-
Hi, and good morning, everyone. My name is Peter Nyquist. I'm the Head of Investor Relations here at Elekta. With me here in Stockholm, I have our CEO, Jonas Bolander; and our CFO, Tobias Hagglov, who will be presenting the results from the first quarter of this fiscal year '25, '26.
So we will start with the normal agenda with Jonas presenting some highlights from the development during the first quarter as well as some achievements we have reached during the quarter. Then, Tobias will bring us down to more details on the financials. And then we will have an outlook from Jonas by the end of the presentation. And as always, after presentation, we will end with a Q&A.
But before starting, I want to remind you that some of the information discussed on this call contains forward-looking statements. This can include projects -- projections regarding revenue, operating result, cash flow, as well as products and product development. These statements involves risks and uncertainties that may cause
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
